ANTB Financials 07/16/2014 14:55:03 AntriaBio, In
Post# of 8
AntriaBio, Inc.
Period Ending Jun 30, 2013 Jun 30, 2012 Dec 31, 2011 Jun 30, 2011
Total Revenue - - - -
Cost of Revenue 101 5 10 -
Gross Profit (101) (5) (10) -
Operating Expenses
Research and Development 3 - - 25
Sales, General and Admin. 6,002 43 383 17
Non-Recurring Items - 2 - -
Other - - - -
Operating Income (6,107) (49) (393) (42)
Income From Continuing Operations
Add'l Income/Expense Items (52) - 7 -
Earnings Before Interest and Tax (6,159) (49) (386) (42)
Interest Expense 569 - 204 -
Earnings Before Tax (6,727) (49) (590) (42)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (6,727) (49) (590) (42)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (6,727) (49) (590) (42)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (6,727) (49) (590) (42)